Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1991 Nov;67(793):1018–1020. doi: 10.1136/pgmj.67.793.1018

Polymyositis complicating D-penicillamine treatment.

A O Aydintug 1, R Cervera 1, D D'Cruz 1, G Ramírez 1, R A Asherson 1, M A Khamashta 1, G R Hughes 1
PMCID: PMC2399149  PMID: 1775410

Abstract

Although there is good evidence that D-penicillamine can induce polymyositis, the exact pathogenic mechanism remains unclear. We report two patients with psoriatic arthritis and primary biliary cirrhosis respectively, who developed polymyositis while receiving D-penicillamine treatment for their primary diseases. Whether D-penicillamine treatment was the sole cause of polymyositis or acted as a trigger for the development of a secondary autoimmune disease is discussed.

Full text

PDF
1018

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bohan A., Peter J. B. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975 Feb 20;292(8):403–407. doi: 10.1056/NEJM197502202920807. [DOI] [PubMed] [Google Scholar]
  2. Bucknall R. C., Dixon A St J., Glick E. N., Woodland J., Zutshi D. W. Myasthenia gravis associated with penicillamine treatment for rheumatoid arthritis. Br Med J. 1975 Mar 15;1(5958):600–602. doi: 10.1136/bmj.1.5958.600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Carroll G. J., Will R. K., Peter J. B., Garlepp M. J., Dawkins R. L. Penicillamine induced polymyositis and dermatomyositis. J Rheumatol. 1987 Oct;14(5):995–1001. [PubMed] [Google Scholar]
  4. Crouzet J., Camus J. P., Leca A. P., Guillien P., Lièvre J. A. Lupus induit par la D-pénicillamine au cours du traitement de la polyarthrite rhumatoïde. Deux observation et étude immunologique systématique au cours de ce traitment. Ann Med Interne (Paris) 1974 Jan;125(1):71–79. [PubMed] [Google Scholar]
  5. Cucher B. G., Goldman A. L. D-penicillamine-induced polymyositis in rheumatoid arthritis. Ann Intern Med. 1976 Nov;85(5):615–616. doi: 10.7326/0003-4819-85-5-615. [DOI] [PubMed] [Google Scholar]
  6. Dawkins R. L., Zilko P. J., Carrano J., Garlepp M. J., McDonald B. L. Immunobiology of D-penicillamine. J Rheumatol Suppl. 1981 Jan-Feb;7:56–61. [PubMed] [Google Scholar]
  7. Doyle D. R., McCurley T. L., Sergent J. S. Fatal polymyositis in D-penicillamine-treated rheumatoid arthritis. Ann Intern Med. 1983 Mar;98(3):327–330. doi: 10.7326/0003-4819-98-3-327. [DOI] [PubMed] [Google Scholar]
  8. Essigman W. K. Multiple side effects of penicillamine therapy in one patient with rheumatoid arthritis. Ann Rheum Dis. 1982 Dec;41(6):617–620. doi: 10.1136/ard.41.6.617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fernandes L., Swinson D. R., Hamilton E. B. Dermatomyositis complicating penicillamine treatment. Ann Rheum Dis. 1977 Feb;36(1):94–95. doi: 10.1136/ard.36.1.94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fischer R. G., Pennebaker J. B. Penicillamine-induced polymyositis in a patient with rheumatoid arthritis. South Med J. 1981 Oct;74(10):1286–1286. doi: 10.1097/00007611-198110000-00042. [DOI] [PubMed] [Google Scholar]
  11. Harpey J. P., Caille B., Moulias R., Goust J. M. Lupus-like syndrome induced by D-penicillamine in Wilson's disease. Lancet. 1971 Feb 6;1(7693):292–292. doi: 10.1016/s0140-6736(71)91022-1. [DOI] [PubMed] [Google Scholar]
  12. Marsden R. A., Vanhegan R. I., Walshe M., Hill H., Mowat A. G. Pemphigus foliaceus induced by penicillamine. Br Med J. 1976 Dec 11;2(6049):1423–1424. doi: 10.1136/bmj.2.6049.1423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. May V., Aristoff H., Lecoq G. Syndrome de Gougerot-Sjögren induit par la D-pénicillamine. A propos d'un cas. Rev Rhum Mal Osteoartic. 1977 Jul-Sep;44(7-9):497–501. [PubMed] [Google Scholar]
  14. Petersen J., Halberg P., Højgaard K., Lyon B. B., Ullman S. Penicillamine-induced polymyositis-dermatomyositis. Scand J Rheumatol. 1978;7(2):113–117. doi: 10.3109/03009747809098847. [DOI] [PubMed] [Google Scholar]
  15. Schraeder P. L., Peters H. A., Dahl D. S. Polymyositis and penicillamine. Arch Neurol. 1972 Nov;27(5):456–457. doi: 10.1001/archneur.1972.00490170088013. [DOI] [PubMed] [Google Scholar]
  16. Sternlieb I., Bennett B., Scheinberg I. H. D-penicillamine induced Goodpasture's syndrome in Wilson's disease. Ann Intern Med. 1975 May;82(5):673–676. doi: 10.7326/0003-4819-82-5-673. [DOI] [PubMed] [Google Scholar]
  17. Takahashi K., Ogita T., Okudaira H., Yoshinoya S., Yoshizawa H., Miyamoto T. D-penicillamine-induced polymyositis in patients with rheumatoid arthritis. Arthritis Rheum. 1986 Apr;29(4):560–564. doi: 10.1002/art.1780290416. [DOI] [PubMed] [Google Scholar]
  18. Urbano-Márquez A., Casademont J., Grau J. M. Polymyositis/dermatomyositis: the current position. Ann Rheum Dis. 1991 Mar;50(3):191–195. doi: 10.1136/ard.50.3.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Van Der Korst J. K., Muijsers A. O., Henrichs A. M., Ament H. J., Van De Stadt R. J. Blood levels and side-effects of D-penicillamine. Agents Actions Suppl. 1979;(5):159–167. [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES